AI Is About to Redesign Life Itself: SynBioBeta's John Cumbers Explains

Join host Flo Lumsden as she sits down with John Cumbers, CEO and founder of SynBioBeta, at the world's largest synthetic biology conference this past May. In this conversation, John shares how AI is fundamentally reshaping the field of biology — from large language models designing novel enzymes and antibodies to full-stack scientific innovation.

Discover the most exciting breakthroughs happening right now, including xenotransplantation with humanized pig organs, consumer biotech products like probiotic hangover cures, and genetically engineered glowing plants. John also reveals what he's most excited about at the intersection of AI and biotech, the challenges that lie ahead, and why he believes we're approaching AGI (Artificial General Intelligence).

Plus, learn the origin story of SynBioBeta — how a small meeting of 150 people in a law firm grew into a 2,000+ person conference with over 100 exhibitors and sponsors — and why creating community and "paying it forward" is at the heart of everything he does.

Outline with Timecodes:
00:00 - Introduction & Podcast Overview 
00:36 - SynBioBeta Origin Story 
02:17 - John Cumbers, CEO & Founder Introduction 
02:23 - Evolution of SynBioBeta: From 150 to 2,000+ Attendees 
02:57 - John's Passion for Event Production & Community Building 
03:42 - "Paying It Forward" Culture & Success Stories 
04:31 - Science as a Competitive Advantage for Startups 
05:18 - AI at the Intersection of Biotech 
05:30 - Large Language Models for Genes and Genomes 
06:22 - How AI is Designing Novel Enzymes & Organisms 
07:03 - Antibody Development for Drug Discovery 
07:14 - Challenges & Limitations of AI Implementation 
08:09 - Healthcare Innovations: Xenotransplantation 
08:55 - Consumer Biotech Applications 
09:03 - Zbiotics & Probiotic Products 
09:18 - GLP-1 Peptides & Cellular Reprogramming 
10:17 - New Innovations: Glowing Plants & Hardware/Software Tools 
11:04 - Full-Stack AI Integration in Biotech 
12:12 - SynBioBeta 2026 Themes & Community Sessions 
13:00 - Closing Remarks